A Case of Rapidly Progressing Hepatocellular Carcinoma after Administration of JAK Inhibitors to Treat Rheumatoid Arthritis

<div>Clinical course of the patient. ALT: alanine aminotransferase; AST: aspartate aminotransferase; BAR: baricitinib; cre: creatinine; CRP: C-reactive protein; CT: computed tomography; IGU: iguratimod; MRI: magnetic resonance imaging; PSL: prednisolone; SASP: salazosulfapyridine; TOF: tofacitinib.</div>

Case Reports in Rheumatology

fig2

Figure 2

Figure 2: A Case of Rapidly Progressing Hepatocellular Carcinoma after Administration of JAK Inhibitors to Treat Rheumatoid Arthritis 